Overall Survival Results of a Trial Assessing Patient-Reported Outcomes for Symptom Monitoring During Routine Cancer Treatment

JAMA. 2017 Jul 11;318(2):197-198. doi: 10.1001/jama.2017.7156.

Authors

Ethan Basch¹, Allison M Deal², Amylou C Dueck³, Howard I Scher⁴, Mark G Kris⁴, Clifford Hudis⁵, Deborah Schrag⁶

Affiliations

¹ Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill2Associate Editor, JAMA.
² Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill.
³ Mayo Clinic, Scottsdale, Arizona.
⁴ Memorial Sloan Kettering Cancer Center, New York, New York.
⁵ American Society of Clinical Oncology, Alexandria, Virginia.
⁶ Associate Editor, JAMA6Dana-Farber/Harvard Cancer Center, Boston, Massachusetts.

Abstract

This study assesses overall survival associated with electronic patient-reported symptom monitoring vs usual care during routine cancer treatment.

Publication types

Comparative Study
Letter

MeSH terms

Adult
Aged
Aged, 80 and over
Female
Follow-Up Studies
Humans
Male
Middle Aged
Neoplasm Metastasis
Neoplasms / complications*
Neoplasms / mortality
Neoplasms / therapy
Patient Reported Outcome Measures*
Quality of Life*
Randomized Controlled Trials as Topic
Survival Analysis
Symptom Assessment